Skip to content
Biodatica
Start free

Investigator

X. Charlie Dong

INDIANA UNIVERSITY INDIANAPOLIS · funded by NIAAA

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.1M

Summed across those awards.

First award
May 1, 2022

Latest Sep 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    Elucidation of the alcohol effect on tumor suppressor genes

    $228k

    Sep 1, 2025NIAAAINDIANA UNIVERSITY INDIANAPOLISNIH RePORTER · 11117928 (opens the source filing in a new tab)

  2. R01

    The pathophysiological function of PNPLA3-148M variant in alcohol-induced liver injury

    $447k

    May 1, 2022NIAAAINDIANA UNIVERSITY INDIANAPOLISNIH RePORTER · 11055411 (opens the source filing in a new tab)

  3. R01

    The pathophysiological function of PNPLA3-148M variant in alcohol-induced liver injury

    $447k

    May 1, 2022NIAAAINDIANA UNIVERSITY INDIANAPOLISNIH RePORTER · 11325419 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources